2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
RESTRICTED
Published on
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) European Heart Journal 2020;42:255-323These guidelines provide direction on the management and prevention of cardiovascular disease (CVD) in subjects with, an...
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
RESTRICTED
Published on
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)European Heart Journal, 2020Publication of this update to the 2016 guidelines follows emergence of a substantial body of evidence pertaining to low-density lipoprotein-C (LDL-C) reductions and risk of atherosclerotic cardiovascular disease (ASCVD). Monitoring LDL-C for longer periods is now required, with new g...
Cardiovascular disease and risk management: standards of care in diabetes – 2020
RESTRICTED
Published on
American Diabetes AssociationDiabetes Care, 2020The American Diabetes Association (ADA) Standards of Medical Care in Diabetes outlines current clinical practice recommendations for diabetes care, including treatment goals, tools to evaluate quality of care and recommendations for lipid profile monitoring (which can be conducted via POC testing). The guidelines recommend obtaining a lipid profile at the time of diabetes diagnosis, at an initial me...
Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabete...
Published on
Join our panel of experts from around the world to learn about Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabetes and non diabetes patients. The webinar will analyse studies and present front line experience on the value of point of care testing told through the eyes of internationally acclaimed health care professionals and academics from Germany...
Access Now
By using this site, you agree with our use of cookies.
